Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
about
Glycemic variability and glycemic control in the acutely ill cardiac patientNeurocardiological differences between musicians and control subjects.Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetesDendritic peptide release mediates interpopulation crosstalk between neurosecretory and preautonomic networks.Propensity score-based diagnostics for categorical response regression models.Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity.
P2860
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@ast
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@en
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@nl
type
label
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@ast
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@en
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@nl
prefLabel
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@ast
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@en
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@nl
P2093
P2860
P356
P1476
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept
@en
P2093
M Fasshauer
R U Pliquett
P2860
P2888
P356
10.1186/1475-2840-3-4
P407
P577
2004-03-17T00:00:00Z
P5875
P6179
1043692629